Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
2.580
-0.410 (-13.71%)
Nov 20, 2024, 4:00 PM EST - Market closed
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $95.20 million as of November 20, 2024. Its market cap has decreased by -78.50% in one year.
Market Cap
95.20M
Enterprise Value
36.74M
1-Year Change
-78.50%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $95.20M, a decrease of -82.80%. That is a compound annual growth rate of -78.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 110.70M | -66.63% |
Dec 29, 2023 | 331.73M | -40.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
TELA Bio | 113.04M |
Milestone Pharmaceuticals | 112.61M |
TriSalus Life Sciences | 111.90M |
Fennec Pharmaceuticals | 110.69M |
Eupraxia Pharmaceuticals | 109.04M |
INmune Bio | 107.98M |
Leap Therapeutics | 106.38M |
Century Therapeutics | 106.29M |